Results for tag: "Age Related Macular Degeneration Drug"

The Age Related Macular Degeneration (AMD) Drug market is a subset of the Optical Disorders Drugs market. AMD is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. AMD is the leading cause of vision loss in people over the age of 50. Treatment options for AMD include drugs, laser therapy, and surgery. Drugs used to treat AMD include anti-VEGF drugs, which block the growth of abnormal blood vessels in the eye, and corticosteroids, which reduce inflammation. These drugs are typically administered via intravitreal injections. The AMD Drug market is highly competitive, with a number of companies offering treatments. These include Regeneron Pharmaceuticals, Novartis, Allergan, and Roche. Show Less Read more